Skip to main content

Improving early diagnosis in cancer: what can be done to identify seldom heard groups and improve outcomes?

15 Jun 2023
Central 4
Health inequalities improvement , Supporter session

This session will explore health inequalities and improving access to seldom heard groups in the context of cancer services. Speakers will discuss meaningful action being taken to address inequalities for patients, and how we can improve early diagnosis rates for all patients.

The session will identify priorities for driving this agenda, as well as sharing best practice and examples of local activity, with a focus on both successes and learnings.

This session is supported by Janssen.

Jane Lyons, CEO - Cancer52
Alison Jones, Director of Commissioning & Early Diagnosis - Greater Manchester Cancer Alliance
Professor Bola Owolabi, Director – Healthcare Inequalities Improvement - NHS England
Roz Bekker, Managing Director UK & Ireland - Janssen